X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Religare Enterprises with Indoco Remedies - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RELIGARE ENT. vs INDOCO REMEDIES - Comparison Results

RELIGARE ENT.    Change

Promoted by Mr. Malvinder Mohan Singh and Mr. Shivinder Mohan Singh , Religare Enterprises is a financial services company, offering a wide range of financial products and services targeted at retail investors, high net worth individuals and corporat... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RELIGARE ENT. INDOCO REMEDIES RELIGARE ENT./
INDOCO REMEDIES
 
P/E (TTM) x 18.6 22.9 81.5% View Chart
P/BV x 0.3 2.7 9.8% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 RELIGARE ENT.   INDOCO REMEDIES
EQUITY SHARE DATA
    RELIGARE ENT.
Mar-16
INDOCO REMEDIES
Mar-17
RELIGARE ENT./
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs395360 109.6%   
Low Rs256249 102.8%   
Sales per share (Unadj.) Rs218.0119.0 183.1%  
Earnings per share (Unadj.) Rs-2.38.4 -28.0%  
Cash flow per share (Unadj.) Rs-0.615.2 -3.8%  
Dividends per share (Unadj.) Rs01.60 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs190.070.7 268.7%  
Shares outstanding (eoy) m203.3392.15 220.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.52.6 58.3%   
Avg P/E ratio x-138.936.4 -381.1%  
P/CF ratio (eoy) x-561.020.0 -2,803.6%  
Price / Book Value ratio x1.74.3 39.8%  
Dividend payout %019.1 0.0%   
Avg Mkt Cap Rs m66,18428,083 235.7%   
No. of employees `000NA6.0 0.0%   
Total wages/salary Rs m9,3362,167 430.9%   
Avg. sales/employee Rs ThNM1,817.0-  
Avg. wages/employee Rs ThNM359.0-  
Avg. net profit/employee Rs ThNM127.7-  
INCOME DATA
Net Sales Rs m44,31810,968 404.1%  
Other income Rs m70940 1,784.6%   
Total revenues Rs m45,02611,007 409.1%   
Gross profit Rs m23,7231,565 1,516.2%  
Depreciation Rs m359633 56.7%   
Interest Rs m18,72162 30,147.2%   
Profit before tax Rs m5,351909 588.4%   
Minority Interest Rs m-1,0850-   
Prior Period Items Rs m60-   
Extraordinary Inc (Exp) Rs m-2,5330-   
Tax Rs m2,215139 1,597.1%   
Profit after tax Rs m-477771 -61.8%  
Gross profit margin %53.514.3 375.2%  
Effective tax rate %41.415.3 271.4%   
Net profit margin %-1.17.0 -15.3%  
BALANCE SHEET DATA
Current assets Rs m94,9575,725 1,658.7%   
Current liabilities Rs m103,0365,454 1,889.1%   
Net working cap to sales %-18.22.5 -738.6%  
Current ratio x0.91.0 87.8%  
Inventory Days Days562 7.6%  
Debtors Days Days3872 53.2%  
Net fixed assets Rs m17,8905,307 337.1%   
Share capital Rs m2,033184 1,103.3%   
"Free" reserves Rs m33,9996,331 537.0%   
Net worth Rs m38,6296,516 592.9%   
Long term debt Rs m118,5831,323 8,962.5%   
Total assets Rs m274,29311,970 2,291.6%  
Interest coverage x1.315.6 8.2%   
Debt to equity ratio x3.10.2 1,511.7%  
Sales to assets ratio x0.20.9 17.6%   
Return on assets %6.77.0 95.6%  
Return on equity %-1.211.8 -10.4%  
Return on capital %13.012.4 105.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m121,141 1.0%   
Net fx Rs m-123,366 -0.4%   
CASH FLOW
From Operations Rs m-21,540886 -2,430.1%  
From Investments Rs m5,149-1,706 -301.9%  
From Financial Activity Rs m18,5311,316 1,408.4%  
Net Cashflow Rs m2,139497 430.8%  

Share Holding

Indian Promoters % 50.9 59.2 86.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.9 12.5 7.2%  
FIIs % 15.3 6.0 255.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 32.9 22.4 146.9%  
Shareholders   26,518 12,805 207.1%  
Pledged promoter(s) holding % 68.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RELIGARE ENT. With:   REPCO HOME  FUTURE CONSUMER  IIFL HOLDINGS  EDELWEISS FINANCIAL  TALWALKARS BETTER VAL.  



Today's Market

Sensex Trades Marginally Higher; Pharma Stocks Among Top Gainers(01:30 pm)

After opening the day in green, share markets in India witnessed choppy trades and are presently trading marginally above the dotted line.

Related Views on News

Insider at It Again. This Time Stealing from Buffett and Berkshire (The 5 Minute Wrapup)

Aug 12, 2017

What is Equitymaster Insider Ankit Shah stealing from Berkshire's success?

HDFC: Red Flag in Developer Loans (Quarterly Results Update - Detailed)

Aug 10, 2017

HDFC starts FY18 on robust loan growth but asset quality slips on increased exposure to developer loans.

Shriram Trans Fin: FY17 Ends on a Tepid Note due to Regulatory Headwinds (Quarterly Results Update - Detailed)

Jun 22, 2017

Demonetisation led slowdown coupled with shift to stringent bad loan norms keep Shriram Transport Finance on a slow wicket.

Central Depository Services (India) Ltd. (IPO)

Jun 19, 2017

Should one subscribe to the IPO of CDSL Ltd?

Power Finance Corp: Alignment with RBI Norms Knocks Down FY17 Earnings (Quarterly Results Update - Detailed)

Jun 14, 2017

Power Finance Corporation earnings hit by RBI mandated higher provision on state government power generation projects where the recovery continues to be 100%.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RELIGARE ENT. SHARE PRICE


Aug 22, 2017 03:08 PM

TRACK RELIGARE ENT.

  • Track your investment in RELIGARE ENT. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RELIGARE ENT. 8-QTR ANALYSIS

COMPARE RELIGARE ENT. WITH

MARKET STATS